Roby Zomer
Follow
Get notifications in MyBN when activity occurs.
Roby Zomer
Co-Founder, Chief Executive & Managing Director / MGC Pharmaceuticals
Roby Zomer has over 9 years of strong corporate and operational experience within the field of eco sustainable projects, and achieved international success within the biotech and agritech sectors.
Mr Zomer was also founder and chief executive of Green City Urban Recycling, an Israeli renewable energy company with strong social and environmental values, where he was a representative of the biofuels industry to the Government of Israel, giving him an extensive background in international and government relations as well as emerging industries. He also led the 48% sale of the company to the high profile global defense systems company, RAFEAL (inventor of the Iron Dome, a mobile all-weather air defense system). Mr Zomer was also responsible for establishing energy projects in Brazil, Italy, Montenegro and Jordan.
Mr Zomer founded MGC Pharmaceuticals in 2015 and has been instrumental in developing the company’s research and development operations. He played a critical role in progressing its epilepsy and dermatological skin care research programs, which led to clinical study to evaluate its medical cannabis product as a viable treatment for epilepsy amongst children and adolescents at University Children’s Hospital Ljubljana, one of the largest hospitals in central Europe.
Mr Zomer was also founder and chief executive of Green City Urban Recycling, an Israeli renewable energy company with strong social and environmental values, where he was a representative of the biofuels industry to the Government of Israel, giving him an extensive background in international and government relations as well as emerging industries. He also led the 48% sale of the company to the high profile global defense systems company, RAFEAL (inventor of the Iron Dome, a mobile all-weather air defense system). Mr Zomer was also responsible for establishing energy projects in Brazil, Italy, Montenegro and Jordan.
Mr Zomer founded MGC Pharmaceuticals in 2015 and has been instrumental in developing the company’s research and development operations. He played a critical role in progressing its epilepsy and dermatological skin care research programs, which led to clinical study to evaluate its medical cannabis product as a viable treatment for epilepsy amongst children and adolescents at University Children’s Hospital Ljubljana, one of the largest hospitals in central Europe.
Lists and Charts
Total Shareholder Return as at 31/05/22
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 685th | Elmore | 3% | 4% |
| 1078th | Adveritas | -17% | -24% |
| 1191st | Hazer Group | -25% | 8% |
| 1637th | MGC Pharmaceuticals | -54% | -13% |
| 1876th | DW8 | -78% | 17% |
1818 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Elmore | $2.6m |
| 117th |  | MGC Pharmaceuticals | $3.8m |
| 128th | | DW8 | $2.8m |
| 129th |  | Adveritas | $2.7m |
| 131st | | Hazer Group | $2.7m |
207 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: President, Chief Technical Officer, MGC Pharmaceuticals | 01 Sep 2020 |
| REMUNERATION UPDATE: Co-Founder, Chief Executive & Managing Director , MGC Pharmaceuticals | 24 Aug 2020 |
| REMUNERATION UPDATE: Co-Founder, Chief Executive & Managing Director , MGC Pharmaceuticals | 30 Jun 2020 |
